| 前收市價 | 19.44 |
| 開市 | 21.48 |
| 買盤 | 22.34 x 200 |
| 賣出價 | 22.45 x 100 |
| 今日波幅 | 20.56 - 22.51 |
| 52 週波幅 | 15.81 - 41.06 |
| 成交量 | |
| 平均成交量 | 1,970,595 |
| 市值 | 2.727B |
| Beta 值 (5 年，每月) | 0.92 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -4.28 |
| 業績公佈日 | 2024年8月01日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 36.65 |
ZacksCompared to Estimates, Guardant Health (GH) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ZacksGuardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates
Guardant Health (GH) delivered earnings and revenue surprises of 36.11% and 11.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksGuardant (GH) Gears Up for Q1 Earnings: Here's What to Expect
Investors' focus will likely be on revenues generated by Guardant Health (GH) from its precision oncology testing business.
